Chidamide Combined With Sintilimab and Bevacizumab for the First-line Treatment of Advanced Liver Cancer
Clinical trial NCT06408623 · UNKNOWN
Trial details
- NCT number
- NCT06408623
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-15
- Primary completion
- 2025-05-15
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.